225 related articles for article (PubMed ID: 21194624)
1. DNA interaction and cytotoxicity studies of new ruthenium(II) cyclopentadienyl derivative complexes containing heteroaromatic ligands.
Moreno V; Font-Bardia M; Calvet T; Lorenzo J; Avilés FX; Garcia MH; Morais TS; Valente A; Robalo MP
J Inorg Biochem; 2011 Feb; 105(2):241-9. PubMed ID: 21194624
[TBL] [Abstract][Full Text] [Related]
2. One pot synthesis of Cu(II) 2,2'-bipyridyl complexes of 5-hydroxy-hydurilic acid and alloxanic acid: synthesis, crystal structure, chemical nuclease activity and cytotoxicity.
Dixit N; Koiri RK; Maurya BK; Trigun SK; Höbartner C; Mishra L
J Inorg Biochem; 2011 Feb; 105(2):256-67. PubMed ID: 21194626
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of cancer cell growth by ruthenium(II) cyclopentadienyl derivative complexes with heteroaromatic ligands.
Helena Garcia M; Morais TS; Florindo P; Piedade MF; Moreno V; Ciudad C; Noe V
J Inorg Biochem; 2009 Mar; 103(3):354-61. PubMed ID: 19128838
[TBL] [Abstract][Full Text] [Related]
4. New π-arene ruthenium(II) piano-stool complexes with nitrogen ligands.
Grau J; Noe V; Ciudad C; Prieto MJ; Font-Bardia M; Calvet T; Moreno V
J Inorg Biochem; 2012 Apr; 109():72-81. PubMed ID: 22387934
[TBL] [Abstract][Full Text] [Related]
5. From hydrolytically labile to hydrolytically stable Ru(II)-arene anticancer complexes with carbohydrate-derived co-ligands.
Hanif M; Meier SM; Kandioller W; Bytzek A; Hejl M; Hartinger CG; Nazarov AA; Arion VB; Jakupec MA; Dyson PJ; Keppler BK
J Inorg Biochem; 2011 Feb; 105(2):224-31. PubMed ID: 21194622
[TBL] [Abstract][Full Text] [Related]
6. Ruthenium nitrosyl complexes with 1,4,7-trithiacyclononane and 2,2'-bipyridine (bpy) or 2-phenylazopyridine (pap) coligands. Electronic structure and reactivity aspects.
De P; Maji S; Chowdhury AD; Mobin SM; Mondal TK; Paretzki A; Lahiri GK
Dalton Trans; 2011 Dec; 40(46):12527-39. PubMed ID: 21986798
[TBL] [Abstract][Full Text] [Related]
7. Vanadium polypyridyl compounds as potential antiparasitic and antitumoral agents: new achievements.
Benítez J; Becco L; Correia I; Leal SM; Guiset H; Pessoa JC; Lorenzo J; Tanco S; Escobar P; Moreno V; Garat B; Gambino D
J Inorg Biochem; 2011 Feb; 105(2):303-12. PubMed ID: 21194632
[TBL] [Abstract][Full Text] [Related]
8. DNA binding and cleavage properties of a newly synthesised Ru(II)-polypyridyl complex.
Ghosh A; Mandoli A; Kumar DK; Yadav NS; Ghosh T; Jha B; Thomas JA; Das A
Dalton Trans; 2009 Nov; (42):9312-21. PubMed ID: 20449211
[TBL] [Abstract][Full Text] [Related]
9. Influence of PPh₃ moiety in the anticancer activity of new organometallic ruthenium complexes.
Sáez R; Lorenzo J; Prieto MJ; Font-Bardia M; Calvet T; Omeñaca N; Vilaseca M; Moreno V
J Inorg Biochem; 2014 Jul; 136():1-12. PubMed ID: 24690555
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, cellular uptake, apopotosis, cytotoxicity, cell cycle arrest, interaction with DNA and antioxidant activity of ruthenium(II) complexes.
Huang HL; Li ZZ; Liang ZH; Yao JH; Liu YJ
Eur J Med Chem; 2011 Aug; 46(8):3282-90. PubMed ID: 21570748
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, characterization, and DNA binding of new water-soluble cyclopentadienyl ruthenium(II) complexes incorporating phosphines.
Romerosa A; Campos-Malpartida T; Lidrissi C; Saoud M; Serrano-Ruiz M; Peruzzini M; Garrido-Cárdenas JA; García-Maroto F
Inorg Chem; 2006 Feb; 45(3):1289-98. PubMed ID: 16441141
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxicity of half sandwich ruthenium(II) complexes with strong hydrogen bond acceptor ligands and their mechanism of action.
Das S; Sinha S; Britto R; Somasundaram K; Samuelson AG
J Inorg Biochem; 2010 Feb; 104(2):93-104. PubMed ID: 19913918
[TBL] [Abstract][Full Text] [Related]
13. Ru(II)/clotrimazole/diphenylphosphine/bipyridine complexes: Interaction with DNA, BSA and biological potential against tumor cell lines and Mycobacterium tuberculosis.
Colina-Vegas L; Dutra JL; Villarreal W; de A Neto JH; Cominetti MR; Pavan F; Navarro M; Batista AA
J Inorg Biochem; 2016 Sep; 162():135-145. PubMed ID: 27383651
[TBL] [Abstract][Full Text] [Related]
14. DNA interaction, antioxidant activity, and bioactivity studies of two ruthenium(II) complexes.
Han BJ; Jiang GB; Yao JH; Li W; Wang J; Huang HL; Liu YJ
Spectrochim Acta A Mol Biomol Spectrosc; 2015 Jan; 135():840-9. PubMed ID: 25150435
[TBL] [Abstract][Full Text] [Related]
15. The contrasting chemistry and cancer cell cytotoxicity of bipyridine and bipyridinediol ruthenium(II) arene complexes.
Bugarcic T; Habtemariam A; Stepankova J; Heringova P; Kasparkova J; Deeth RJ; Johnstone RD; Prescimone A; Parkin A; Parsons S; Brabec V; Sadler PJ
Inorg Chem; 2008 Dec; 47(24):11470-86. PubMed ID: 19007206
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, single-crystal and solution structure analysis and in vitro cytotoxic activity of two novel complexes of ruthenium(II) with in situ formed flavanone-based ligands.
Ochocki J; Kasprzak M; Chęcińska L; Erxleben A; Zyner E; Szmigiero L; Garza-Ortiz A; Reedijk J
Dalton Trans; 2010 Oct; 39(40):9711-8. PubMed ID: 20830400
[TBL] [Abstract][Full Text] [Related]
17. Tetranuclear coordination assemblies based on half-sandwich ruthenium(II) complexes: noncovalent binding to DNA and cytotoxicity.
Linares F; Galindo MA; Galli S; Romero MA; Navarro JA; Barea E
Inorg Chem; 2009 Aug; 48(15):7413-20. PubMed ID: 19586019
[TBL] [Abstract][Full Text] [Related]
18. New cytotoxic and water-soluble bis(2-phenylazopyridine)ruthenium(II) complexes.
Hotze AC; Bacac M; Velders AH; Jansen BA; Kooijman H; Spek AL; Haasnoot JG; Reedijk J
J Med Chem; 2003 Apr; 46(9):1743-50. PubMed ID: 12699392
[TBL] [Abstract][Full Text] [Related]
19. Non-classical anticancer agents: synthesis and biological evaluation of zinc(II) heteroleptic complexes.
Liguori PF; Valentini A; Palma M; Bellusci A; Bernardini S; Ghedini M; Panno ML; Pettinari C; Marchetti F; Crispini A; Pucci D
Dalton Trans; 2010 May; 39(17):4205-12. PubMed ID: 20390185
[TBL] [Abstract][Full Text] [Related]
20. Highly active neutral ruthenium(II) arene complexes: synthesis, characterization, and investigation of their anticancer properties.
Ludwig G; Kaluđerović GN; Bette M; Block M; Paschke R; Steinborn D
J Inorg Biochem; 2012 Aug; 113():77-82. PubMed ID: 22698819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
